As big pharma exits Nigeria, asthma patients face spiralling costs


Price of asthma inhalers has more than doubled amid scarcity and added costs after GSK exited Nigerian market in 2023.


Click here to: Read More 

Leave a Comment

About Us

A social enterprise that provides accurate and accessible information about the Republic of Sudan across various sectors through rigorous information collection and analysis

Contact Us

© 2024 SudanFacts. A Facts Center for Journalism Services Publication. All Right Reserved.